{
    "abstract": "Gastric adenocarcinoma is globally the third leading cause of death due to malignancy, with the bulk of this disease burden being suffered by low and middle income countries (LMIC), especially in Asia. The majority of these cancers develop as a result of a chronic gastritis that arises in response to infection with the stomach-dwelling bacterium, Helicobacter pylori. A vaccine against this pathogen would therefore be a powerful tool for preventing gastric adenocarcinoma. However, notwithstanding a proof-of-concept that vaccination can protect children from acquisition of H. pylori infection, there are currently no advanced vaccine candidates with only a single vaccine in Phase I clinical trial. Further, the development of a vaccine against H. pylori is not a current strategic priority of major pharmaceutical companies despite the large global disease burden. Given the involvement of such companies is likely to be critical for late stage development, there is therefore a need for an increased appreciation of the burden of this disease in LMIC and more investment to reinvigorate research in H. pylori vaccine Research and Development.",
    "bib_entries": {
        "b0005": {
            "authors": [
                {
                    "first": "Mutsuko",
                    "initial": "M.",
                    "last": "Konno"
                },
                {
                    "first": "Shin Ichi",
                    "initial": "S.I.",
                    "last": "Yokota"
                },
                {
                    "first": "Toshihiro",
                    "initial": "T.",
                    "last": "Suga"
                },
                {
                    "first": "Michiko",
                    "initial": "M.",
                    "last": "Takahashi"
                },
                {
                    "first": "Kohei",
                    "initial": "K.",
                    "last": "Sato"
                },
                {
                    "first": "Nobuhiro",
                    "initial": "N.",
                    "last": "Fujii"
                }
            ],
            "doi": "10.1097/INF.0b013e31817d756e",
            "firstpage": "999",
            "issn": "08913668",
            "lastpage": "1003",
            "pmid": "18845980",
            "pub_year": 2008,
            "title": "Predominance of mother-to-child transmission of helicobacter pylori infection detected by random amplified polymorphic DNA fingerprinting analysis in Japanese families",
            "volume": "27"
        },
        "b0010": {
            "authors": [
                {
                    "first": "Julie",
                    "initial": "J.",
                    "last": "Parsonnet"
                },
                {
                    "first": "Haim",
                    "initial": "H.",
                    "last": "Shmuely"
                },
                {
                    "first": "Thomas",
                    "initial": "T.",
                    "last": "Haggerty"
                }
            ],
            "doi": "10.1001/jama.282.23.2240",
            "firstpage": "2240",
            "issn": "00987484",
            "lastpage": "2245",
            "pmid": "10605976",
            "pub_year": 1999,
            "title": "Fecal and oral shedding of Helicobacter pylori from healthy infected adults",
            "volume": "282"
        },
        "b0015": {
            "authors": [
                {
                    "first": "M\u0101rcis",
                    "initial": "M.",
                    "last": "Leja"
                },
                {
                    "first": "Anthony",
                    "initial": "A.",
                    "last": "Axon"
                },
                {
                    "first": "Hermann",
                    "initial": "H.",
                    "last": "Brenner"
                }
            ],
            "doi": "10.1111/hel.12332",
            "firstpage": "3",
            "issn": "10834389",
            "lastpage": "7",
            "pmid": "27531531",
            "pub_year": 2016,
            "title": "Epidemiology of Helicobacter pylori infection",
            "volume": "21"
        },
        "b0020": {
            "authors": [
                {
                    "first": "James K.Y.",
                    "initial": "J.K.Y.",
                    "last": "Hooi"
                },
                {
                    "first": "Wan Ying",
                    "initial": "W.Y.",
                    "last": "Lai"
                },
                {
                    "first": "Wee Khoon",
                    "initial": "W.K.",
                    "last": "Ng"
                },
                {
                    "first": "Michael M.Y.",
                    "initial": "M.M.Y.",
                    "last": "Suen"
                },
                {
                    "first": "Fox E.",
                    "initial": "F.E.",
                    "last": "Underwood"
                },
                {
                    "first": "Divine",
                    "initial": "D.",
                    "last": "Tanyingoh"
                },
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Malfertheiner"
                },
                {
                    "first": "David Y.",
                    "initial": "D.Y.",
                    "last": "Graham"
                },
                {
                    "first": "Vincent W.S.",
                    "initial": "V.W.S.",
                    "last": "Wong"
                },
                {
                    "first": "Justin C.Y.",
                    "initial": "J.C.Y.",
                    "last": "Wu"
                },
                {
                    "first": "Francis K.L.",
                    "initial": "F.K.L.",
                    "last": "Chan"
                },
                {
                    "first": "Joseph J.Y.",
                    "initial": "J.J.Y.",
                    "last": "Sung"
                },
                {
                    "first": "Gilaad G.",
                    "initial": "G.G.",
                    "last": "Kaplan"
                },
                {
                    "first": "Siew C.",
                    "initial": "S.C.",
                    "last": "Ng"
                }
            ],
            "doi": "10.1053/j.gastro.2017.04.022",
            "firstpage": "420",
            "issn": "00165085",
            "lastpage": "429",
            "pmid": "28456631",
            "pub_year": 2017,
            "title": "Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis",
            "volume": "153"
        },
        "b0025": {
            "authors": [
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Nagy"
                },
                {
                    "first": "Saga",
                    "initial": "S.",
                    "last": "Johansson"
                },
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Molloy-Bland"
                }
            ],
            "doi": "10.1186/s13099-016-0091-7",
            "issn": "17574749",
            "pub_year": 2016,
            "title": "Systematic review of time trends in the prevalence of Helicobacter pylori infection in China and the USA",
            "volume": "8"
        },
        "b0030": {
            "authors": [
                {
                    "first": "Caroline M.",
                    "initial": "C.M.",
                    "last": "den Hoed"
                },
                {
                    "first": "Anne J.",
                    "initial": "A.J.",
                    "last": "Vila"
                },
                {
                    "first": "Ingrid L.",
                    "initial": "I.L.",
                    "last": "Holster"
                },
                {
                    "first": "Guillermo I.",
                    "initial": "G.I.",
                    "last": "Perez-Perez"
                },
                {
                    "first": "Martin J.",
                    "initial": "M.J.",
                    "last": "Blaser"
                },
                {
                    "first": "Johan C.",
                    "initial": "J.C.",
                    "last": "de Jongste"
                },
                {
                    "first": "Ernest J.",
                    "initial": "E.J.",
                    "last": "Kuipers"
                }
            ],
            "doi": "10.1111/j.1523-5378.2011.00854.x",
            "firstpage": "405",
            "issn": "10834389",
            "lastpage": "409",
            "pmid": "21923687",
            "pub_year": 2011,
            "title": "Helicobacter pylori and the birth cohort effect: Evidence for stabilized colonization rates in childhood",
            "volume": "16"
        },
        "b0035": {
            "authors": [
                {
                    "first": "P.",
                    "initial": "P.",
                    "last": "Malfertheiner"
                },
                {
                    "first": "F.",
                    "initial": "F.",
                    "last": "Megraud"
                },
                {
                    "first": "C. A.",
                    "initial": "C.A.",
                    "last": "O'Morain"
                },
                {
                    "first": "J. P.",
                    "initial": "J.P.",
                    "last": "Gisbert"
                },
                {
                    "first": "E. J.",
                    "initial": "E.J.",
                    "last": "Kuipers"
                },
                {
                    "first": "A. T.",
                    "initial": "A.T.",
                    "last": "Axon"
                },
                {
                    "first": "F.",
                    "initial": "F.",
                    "last": "Bazzoli"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Gasbarrini"
                },
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "Atherton"
                },
                {
                    "first": "D. Y.",
                    "initial": "D.Y.",
                    "last": "Graham"
                },
                {
                    "first": "R.",
                    "initial": "R.",
                    "last": "Hunt"
                },
                {
                    "first": "P.",
                    "initial": "P.",
                    "last": "Moayyedi"
                },
                {
                    "first": "T.",
                    "initial": "T.",
                    "last": "Rokkas"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Rugge"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Selgrad"
                },
                {
                    "first": "S.",
                    "initial": "S.",
                    "last": "Suerbaum"
                },
                {
                    "first": "K.",
                    "initial": "K.",
                    "last": "Sugano"
                },
                {
                    "first": "E. M.",
                    "initial": "E.M.",
                    "last": "El-Omar"
                },
                {
                    "first": null,
                    "initial": null,
                    "last": null
                }
            ],
            "doi": "10.1136/gutjnl-2012-302084",
            "firstpage": "646",
            "issn": "00175749",
            "lastpage": "664",
            "pmid": "22491499",
            "pub_year": 2012,
            "title": "Management of Helicobacter pylori infection - The Maastricht IV/ Florence consensus report",
            "volume": "61"
        },
        "b0040": {
            "authors": [
                {
                    "first": "Naomi",
                    "initial": "N.",
                    "last": "Uemura"
                },
                {
                    "first": "Shiro",
                    "initial": "S.",
                    "last": "Okamoto"
                },
                {
                    "first": "Soichiro",
                    "initial": "S.",
                    "last": "Yamamoto"
                },
                {
                    "first": "Nobutoshi",
                    "initial": "N.",
                    "last": "Matsumura"
                },
                {
                    "first": "Shuji",
                    "initial": "S.",
                    "last": "Yamaguchi"
                },
                {
                    "first": "Michio",
                    "initial": "M.",
                    "last": "Yamakido"
                },
                {
                    "first": "Kiyomi",
                    "initial": "K.",
                    "last": "Taniyama"
                },
                {
                    "first": "Naomi",
                    "initial": "N.",
                    "last": "Sasaki"
                },
                {
                    "first": "Ronald J.",
                    "initial": "R.J.",
                    "last": "Schlemper"
                }
            ],
            "doi": "10.1056/NEJMoa001999",
            "firstpage": "784",
            "issn": "00284793",
            "lastpage": "789",
            "pmid": "11556297",
            "pub_year": 2001,
            "title": "Helicobacter pylori infection and the development of gastric cancer",
            "volume": "345"
        },
        "b0045": {
            "authors": [
                {
                    "first": "Antonio",
                    "initial": "A.",
                    "last": "Gasbarrini"
                },
                {
                    "first": "Francesco",
                    "initial": "F.",
                    "last": "Franceschi"
                },
                {
                    "first": "Raffaele",
                    "initial": "R.",
                    "last": "Tartaglione"
                },
                {
                    "first": "Raffaele",
                    "initial": "R.",
                    "last": "Landolfi"
                },
                {
                    "first": "Paolo",
                    "initial": "P.",
                    "last": "Pola"
                },
                {
                    "first": "Giovanni",
                    "initial": "G.",
                    "last": "Gasbarrini"
                }
            ],
            "doi": "10.1016/S0140-6736(05)60004-9",
            "firstpage": "878",
            "issn": "01406736",
            "pmid": "9742983",
            "pub_year": 1998,
            "title": "Regression of autoimmune thrombocytopenia after eradication of Helicobacter pylori",
            "volume": "352"
        },
        "b0050": {
            "authors": [
                {
                    "first": "Roberto",
                    "initial": "R.",
                    "last": "Stasi"
                },
                {
                    "first": "Ameet",
                    "initial": "A.",
                    "last": "Sarpatwari"
                },
                {
                    "first": "Jodi B.",
                    "initial": "J.B.",
                    "last": "Segal"
                },
                {
                    "first": "John",
                    "initial": "J.",
                    "last": "Osborn"
                },
                {
                    "first": "Maria Laura",
                    "initial": "M.L.",
                    "last": "Evangelista"
                },
                {
                    "first": "Nichola",
                    "initial": "N.",
                    "last": "Cooper"
                },
                {
                    "first": "Drew",
                    "initial": "D.",
                    "last": "Provan"
                },
                {
                    "first": "Adrian",
                    "initial": "A.",
                    "last": "Newland"
                },
                {
                    "first": "Sergio",
                    "initial": "S.",
                    "last": "Amadori"
                },
                {
                    "first": "James B.",
                    "initial": "J.B.",
                    "last": "Bussel"
                }
            ],
            "doi": "10.1182/blood-2008-07-167155",
            "firstpage": "1231",
            "issn": "00064971",
            "lastpage": "1240",
            "pmid": "18945961",
            "pub_year": 2009,
            "title": "Effects of eradication of Helicobacter pylori infection in patients with immune thrombocytopenic purpura: A systematic review",
            "volume": "113"
        },
        "b0055": null,
        "b0060": {
            "authors": [
                {
                    "first": "Kai Feng",
                    "initial": "K.F.",
                    "last": "Pan"
                },
                {
                    "first": "Lian",
                    "initial": "L.",
                    "last": "Zhang"
                },
                {
                    "first": "Markus",
                    "initial": "M.",
                    "last": "Gerhard"
                },
                {
                    "first": "Jun Ling",
                    "initial": "J.L.",
                    "last": "Ma"
                },
                {
                    "first": "Wei Dong",
                    "initial": "W.D.",
                    "last": "Liu"
                },
                {
                    "first": "Kurt",
                    "initial": "K.",
                    "last": "Ulm"
                },
                {
                    "first": "Jian Xi",
                    "initial": "J.X.",
                    "last": "Wang"
                },
                {
                    "first": "Lei",
                    "initial": "L.",
                    "last": "Zhang"
                },
                {
                    "first": "Yang",
                    "initial": "Y.",
                    "last": "Zhang"
                },
                {
                    "first": "Monther",
                    "initial": "M.",
                    "last": "Bajbouj"
                },
                {
                    "first": "Lan Fu",
                    "initial": "L.F.",
                    "last": "Zhang"
                },
                {
                    "first": "Ming",
                    "initial": "M.",
                    "last": "Li"
                },
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Vieth"
                },
                {
                    "first": "Rui Yong",
                    "initial": "R.Y.",
                    "last": "Liu"
                },
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Quante"
                },
                {
                    "first": "Le Hua",
                    "initial": "L.H.",
                    "last": "Wang"
                },
                {
                    "first": "Stepan",
                    "initial": "S.",
                    "last": "Suchanek"
                },
                {
                    "first": "Tong",
                    "initial": "T.",
                    "last": "Zhou"
                },
                {
                    "first": "Wei Xiang",
                    "initial": "W.X.",
                    "last": "Guan"
                },
                {
                    "first": "Roland",
                    "initial": "R.",
                    "last": "Schmid"
                },
                {
                    "first": "Meinhard",
                    "initial": "M.",
                    "last": "Classen"
                },
                {
                    "first": "Wei Cheng",
                    "initial": "W.C.",
                    "last": "You"
                }
            ],
            "doi": "10.1136/gutjnl-2015-309197",
            "firstpage": "9",
            "issn": "00175749",
            "lastpage": "18",
            "pmid": "25986943",
            "pub_year": 2016,
            "title": "A large randomised controlled intervention trial to prevent gastric cancer by eradication of Helicobacter pylori in Linqu County, China: Baseline results and factors affecting the eradication",
            "volume": "65"
        },
        "b0065": {
            "authors": [
                {
                    "first": "Rolando",
                    "initial": "R.",
                    "last": "Herrero"
                },
                {
                    "first": "Jin Young",
                    "initial": "J.Y.",
                    "last": "Park"
                },
                {
                    "first": "David",
                    "initial": "D.",
                    "last": "Forman"
                }
            ],
            "doi": "10.1016/j.bpg.2014.10.003",
            "firstpage": "1107",
            "issn": "15216918",
            "lastpage": "1114",
            "pmid": "25439075",
            "pub_year": 2014,
            "title": "The fight against gastric cancer - The IARC Working Group report",
            "volume": "28"
        },
        "b0070": {
            "authors": [
                {
                    "first": "Martyn",
                    "initial": "M.",
                    "last": "Plummer"
                },
                {
                    "first": "Silvia",
                    "initial": "S.",
                    "last": "Franceschi"
                },
                {
                    "first": "J\u00e9r\u00f4me",
                    "initial": "J.",
                    "last": "Vignat"
                },
                {
                    "first": "David",
                    "initial": "D.",
                    "last": "Forman"
                },
                {
                    "first": "Catherine",
                    "initial": "C.",
                    "last": "De Martel"
                }
            ],
            "doi": "10.1002/ijc.28999",
            "firstpage": "487",
            "issn": "00207136",
            "lastpage": "490",
            "pmid": "24889903",
            "pub_year": 2015,
            "title": "Global burden of gastric cancer attributable to pylori",
            "volume": "136"
        },
        "b0075": {
            "authors": [
                {
                    "first": "Dominique",
                    "initial": "D.",
                    "last": "Velin"
                },
                {
                    "first": "Kathrin",
                    "initial": "K.",
                    "last": "Straubinger"
                },
                {
                    "first": "Markus",
                    "initial": "M.",
                    "last": "Gerhard"
                }
            ],
            "doi": "10.1111/hel.12336",
            "firstpage": "26",
            "issn": "10834389",
            "lastpage": "29",
            "pmid": "27531535",
            "pub_year": 2016,
            "title": "Inflammation, immunity, and vaccines for Helicobacter pylori infection",
            "volume": "21"
        },
        "b0080": {
            "authors": [
                {
                    "first": "Nasrin",
                    "initial": "N.",
                    "last": "Mirzaei"
                },
                {
                    "first": "Farkhondeh",
                    "initial": "F.",
                    "last": "Poursina"
                },
                {
                    "first": "Sharareh",
                    "initial": "S.",
                    "last": "Moghim"
                },
                {
                    "first": "Niloufar",
                    "initial": "N.",
                    "last": "Rashidi"
                },
                {
                    "first": "Hajieh",
                    "initial": "H.",
                    "last": "Ghasemian Safaei"
                }
            ],
            "doi": "10.1080/1040841X.2017.1291578",
            "firstpage": "631",
            "issn": "1040841X",
            "lastpage": "650",
            "pmid": "28581361",
            "pub_year": 2017,
            "title": "The study of H. pylori putative candidate factors for single- and multi-component vaccine development",
            "volume": "43"
        },
        "b0085": {
            "authors": [
                {
                    "first": "Anna",
                    "initial": "A.",
                    "last": "Walduck"
                },
                {
                    "first": "Leif P.",
                    "initial": "L.P.",
                    "last": "Andersen"
                },
                {
                    "first": "Sukanya",
                    "initial": "S.",
                    "last": "Raghavan"
                }
            ],
            "doi": "10.1111/hel.12252",
            "firstpage": "17",
            "issn": "10834389",
            "lastpage": "25",
            "pmid": "26372820",
            "pub_year": 2015,
            "title": "Inflammation, Immunity, and Vaccines for Helicobacter pylori Infection",
            "volume": "20"
        },
        "b0090": {
            "authors": [
                {
                    "first": "Mario M.",
                    "initial": "M.M.",
                    "last": "D'Elios"
                },
                {
                    "first": "Steven J.",
                    "initial": "S.J.",
                    "last": "Czinn"
                }
            ],
            "doi": "10.1111/hel.12156",
            "firstpage": "19",
            "issn": "10834389",
            "lastpage": "26",
            "pmid": "25167941",
            "pub_year": 2014,
            "title": "Immunity, Inflammation, and Vaccines for Helicobacter pylori",
            "volume": "19"
        },
        "b0095": {
            "authors": [
                {
                    "first": "Philip",
                    "initial": "P.",
                    "last": "Sutton"
                },
                {
                    "first": "Yok Teng",
                    "initial": "Y.T.",
                    "last": "Chionh"
                }
            ],
            "doi": "10.1586/erv.13.20",
            "firstpage": "433",
            "issn": "14760584",
            "lastpage": "441",
            "pmid": "23560923",
            "pub_year": 2013,
            "title": "Why can't we make an effective vaccine against Helicobacter pylori?",
            "volume": "12"
        },
        "b0100": {
            "authors": [
                {
                    "first": "Steven J.",
                    "initial": "S.J.",
                    "last": "Czinn"
                },
                {
                    "first": "Thomas",
                    "initial": "T.",
                    "last": "Blanchard"
                }
            ],
            "doi": "10.1038/nrgastro.2011.1",
            "firstpage": "133",
            "issn": "17595045",
            "lastpage": "140",
            "pmid": "21304478",
            "pub_year": 2011,
            "title": "Vaccinating against Helicobacter pylori infection",
            "volume": "8"
        },
        "b0105": {
            "authors": [
                {
                    "first": "P.",
                    "initial": "P.",
                    "last": "Sutton"
                },
                {
                    "first": "C.",
                    "initial": "C.",
                    "last": "Doidge"
                }
            ],
            "doi": "10.1016/S1590-8658(03)00414-6",
            "firstpage": "675",
            "issn": "15908658",
            "lastpage": "687",
            "pmid": "14620614",
            "pub_year": 2003,
            "title": "Helicobacter pylori vaccines spiral into the new millennium",
            "volume": "35"
        },
        "b0110": {
            "authors": [
                {
                    "first": "H. M.",
                    "initial": "H.M.",
                    "last": "Mitchell"
                },
                {
                    "first": "Y. Y.",
                    "initial": "Y.Y.",
                    "last": "Li"
                },
                {
                    "first": "P. J.",
                    "initial": "P.J.",
                    "last": "Hu"
                },
                {
                    "first": "Q.",
                    "initial": "Q.",
                    "last": "Liu"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Chen"
                },
                {
                    "first": "G. G.",
                    "initial": "G.G.",
                    "last": "Du"
                },
                {
                    "first": "Z. J.",
                    "initial": "Z.J.",
                    "last": "Wang"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Lee"
                },
                {
                    "first": "S. L.",
                    "initial": "S.L.",
                    "last": "Hazell"
                }
            ],
            "doi": "10.1093/infdis/166.1.149",
            "firstpage": "149",
            "issn": "00221899",
            "lastpage": "153",
            "pmid": "1607687",
            "pub_year": 1992,
            "title": "Epidemiology of helicobacter pylori in southern china: Identification of early childhood as the critical period for acquisition",
            "volume": "166"
        },
        "b0115": {
            "authors": [
                {
                    "first": "Ming",
                    "initial": "M.",
                    "last": "Zeng"
                },
                {
                    "first": "Xu Hu",
                    "initial": "X.H.",
                    "last": "Mao"
                },
                {
                    "first": "Jing Xin",
                    "initial": "J.X.",
                    "last": "Li"
                },
                {
                    "first": "Wen De",
                    "initial": "W.D.",
                    "last": "Tong"
                },
                {
                    "first": "Bin",
                    "initial": "B.",
                    "last": "Wang"
                },
                {
                    "first": "Yi Ju",
                    "initial": "Y.J.",
                    "last": "Zhang"
                },
                {
                    "first": "Gang",
                    "initial": "G.",
                    "last": "Guo"
                },
                {
                    "first": "Zhi Jing",
                    "initial": "Z.J.",
                    "last": "Zhao"
                },
                {
                    "first": "Liang",
                    "initial": "L.",
                    "last": "Li"
                },
                {
                    "first": "De Lin",
                    "initial": "D.L.",
                    "last": "Wu"
                },
                {
                    "first": "Dong Shui",
                    "initial": "D.S.",
                    "last": "Lu"
                },
                {
                    "first": "Zhong Ming",
                    "initial": "Z.M.",
                    "last": "Tan"
                },
                {
                    "first": "Hao Yu",
                    "initial": "H.Y.",
                    "last": "Liang"
                },
                {
                    "first": "Chao",
                    "initial": "C.",
                    "last": "Wu"
                },
                {
                    "first": "Da Han",
                    "initial": "D.H.",
                    "last": "Li"
                },
                {
                    "first": "Ping",
                    "initial": "P.",
                    "last": "Luo"
                },
                {
                    "first": "Hao",
                    "initial": "H.",
                    "last": "Zeng"
                },
                {
                    "first": "Wei Jun",
                    "initial": "W.J.",
                    "last": "Zhang"
                },
                {
                    "first": "Jin Yu",
                    "initial": "J.Y.",
                    "last": "Zhang"
                },
                {
                    "first": "Bo Tao",
                    "initial": "B.T.",
                    "last": "Guo"
                },
                {
                    "first": "Feng Cai",
                    "initial": "F.C.",
                    "last": "Zhu"
                },
                {
                    "first": "Quan Ming",
                    "initial": "Q.M.",
                    "last": "Zou"
                }
            ],
            "doi": "10.1016/S0140-6736(15)60310-5",
            "firstpage": "1457",
            "issn": "01406736",
            "lastpage": "1464",
            "pmid": "26142048",
            "pub_year": 2015,
            "title": "Efficacy, safety, and immunogenicity of an oral recombinant Helicobacter pylori vaccine in children in China: a randomised, double-blind, placebo-controlled, phase 3 trial",
            "volume": "386"
        },
        "b0120": {
            "authors": [
                {
                    "first": "Yi Chia",
                    "initial": "Y.C.",
                    "last": "Lee"
                },
                {
                    "first": "Tsung Hsien",
                    "initial": "T.H.",
                    "last": "Chiang"
                },
                {
                    "first": "Chu Kuang",
                    "initial": "C.K.",
                    "last": "Chou"
                },
                {
                    "first": "Yu Kang",
                    "initial": "Y.K.",
                    "last": "Tu"
                },
                {
                    "first": "Wei Chih",
                    "initial": "W.C.",
                    "last": "Liao"
                },
                {
                    "first": "Ming Shiang",
                    "initial": "M.S.",
                    "last": "Wu"
                },
                {
                    "first": "David Y.",
                    "initial": "D.Y.",
                    "last": "Graham"
                }
            ],
            "doi": "10.1053/j.gastro.2016.01.028",
            "firstpage": "1113",
            "issn": "00165085",
            "lastpage": "1124.e5",
            "pmid": "26836587",
            "pub_year": 2016,
            "title": "Association between Helicobacter pylori Eradication and Gastric Cancer Incidence: A Systematic Review and Meta-analysis",
            "volume": "150"
        },
        "b0125": {
            "authors": [
                {
                    "first": "Christian",
                    "initial": "C.",
                    "last": "Schmees"
                },
                {
                    "first": "Christian",
                    "initial": "C.",
                    "last": "Prinz"
                },
                {
                    "first": "Tilman",
                    "initial": "T.",
                    "last": "Treptau"
                },
                {
                    "first": "Roland",
                    "initial": "R.",
                    "last": "Rad"
                },
                {
                    "first": "Ludger",
                    "initial": "L.",
                    "last": "Hengst"
                },
                {
                    "first": "Petra",
                    "initial": "P.",
                    "last": "Voland"
                },
                {
                    "first": "Stefan",
                    "initial": "S.",
                    "last": "Bauer"
                },
                {
                    "first": "Lena",
                    "initial": "L.",
                    "last": "Brenner"
                },
                {
                    "first": "Roland M.",
                    "initial": "R.M.",
                    "last": "Schmid"
                },
                {
                    "first": "Markus",
                    "initial": "M.",
                    "last": "Gerhard"
                }
            ],
            "doi": "10.1053/j.gastro.2007.02.031",
            "firstpage": "1820",
            "issn": "00165085",
            "lastpage": "1833",
            "pmid": "17484877",
            "pub_year": 2007,
            "title": "Inhibition of T-Cell Proliferation by Helicobacter pylori \u03b3-Glutamyl Transpeptidase",
            "volume": "132"
        },
        "b0130": {
            "authors": [
                {
                    "first": "Mathias",
                    "initial": "M.",
                    "last": "Oertli"
                },
                {
                    "first": "Manuel",
                    "initial": "M.",
                    "last": "Noben"
                },
                {
                    "first": "Daniela B.",
                    "initial": "D.B.",
                    "last": "Engler"
                },
                {
                    "first": "Raphaela P.",
                    "initial": "R.P.",
                    "last": "Semper"
                },
                {
                    "first": "Sebastian",
                    "initial": "S.",
                    "last": "Reuter"
                },
                {
                    "first": "Joachim",
                    "initial": "J.",
                    "last": "Maxeiner"
                },
                {
                    "first": "Markus",
                    "initial": "M.",
                    "last": "Gerhard"
                },
                {
                    "first": "Christian",
                    "initial": "C.",
                    "last": "Taube"
                },
                {
                    "first": "Anne",
                    "initial": "A.",
                    "last": "M\u00fcller"
                }
            ],
            "doi": "10.1073/pnas.1211248110",
            "firstpage": "3047",
            "issn": "00278424",
            "lastpage": "3052",
            "pmid": "23382221",
            "pub_year": 2013,
            "title": "Helicobacter pylori \u03b3-glutamyl transpeptidase and vacuolating cytotoxin promote gastric persistence and immune tolerance",
            "volume": "110"
        },
        "b0135": {
            "authors": [
                {
                    "first": "Marianna",
                    "initial": "M.",
                    "last": "Boncristiano"
                },
                {
                    "first": "Silvia Rossi",
                    "initial": "S.R.",
                    "last": "Paccani"
                },
                {
                    "first": "Silvia",
                    "initial": "S.",
                    "last": "Barone"
                },
                {
                    "first": "Cristina",
                    "initial": "C.",
                    "last": "Ulivieri"
                },
                {
                    "first": "Laura",
                    "initial": "L.",
                    "last": "Patrussi"
                },
                {
                    "first": "Dag",
                    "initial": "D.",
                    "last": "Ilver"
                },
                {
                    "first": "Amedeo",
                    "initial": "A.",
                    "last": "Amedei"
                },
                {
                    "first": "Mario Milco",
                    "initial": "M.M.",
                    "last": "D'Elios"
                },
                {
                    "first": "John L.",
                    "initial": "J.L.",
                    "last": "Telford"
                },
                {
                    "first": "Cosima T.",
                    "initial": "C.T.",
                    "last": "Baldari"
                }
            ],
            "doi": "10.1084/jem.20030621",
            "firstpage": "1887",
            "issn": "00221007",
            "lastpage": "1897",
            "pmid": "14676300",
            "pub_year": 2003,
            "title": "The Helicobacter pylori Vacuolating Toxin Inhibits T Cell Activation by Two Independent Mechanisms",
            "volume": "198"
        },
        "b0140": {
            "authors": [
                {
                    "first": "Christopher",
                    "initial": "C.",
                    "last": "Doidge"
                },
                {
                    "first": "Ian",
                    "initial": "I.",
                    "last": "Gust"
                },
                {
                    "first": "Adrian",
                    "initial": "A.",
                    "last": "Lee"
                },
                {
                    "first": "Fiona",
                    "initial": "F.",
                    "last": "Buck"
                },
                {
                    "first": "Stuart",
                    "initial": "S.",
                    "last": "Hazell"
                },
                {
                    "first": "Upender",
                    "initial": "U.",
                    "last": "Manne"
                }
            ],
            "doi": "10.1016/S0140-6736(94)90032-9",
            "firstpage": "914",
            "issn": "01406736",
            "lastpage": "915",
            "pmid": "7908372",
            "pub_year": 1994,
            "title": "Therapeutic Immunisation against hellcobacter Infection",
            "volume": "343"
        },
        "b0145": {
            "authors": [
                {
                    "first": "Philip",
                    "initial": "P.",
                    "last": "Sutton"
                },
                {
                    "first": "John",
                    "initial": "J.",
                    "last": "Wilson"
                },
                {
                    "first": "Tadashi",
                    "initial": "T.",
                    "last": "Kosaka"
                },
                {
                    "first": "Isabelle",
                    "initial": "I.",
                    "last": "Wolowczuk"
                },
                {
                    "first": "Adrian",
                    "initial": "A.",
                    "last": "Lee"
                }
            ],
            "doi": "10.1046/j.1440-1711.2000.00881.x",
            "firstpage": "28",
            "issn": "08189641",
            "lastpage": "30",
            "pmid": "10651926",
            "pub_year": 2000,
            "title": "Therapeutic immunization against Helicobacter pylori infection in the absence of antibodies",
            "volume": "78"
        },
        "b0150": {
            "authors": [
                {
                    "first": "Mareia F.T.",
                    "initial": "M.F.T.",
                    "last": "Rupnow"
                },
                {
                    "first": "Alicia H.",
                    "initial": "A.H.",
                    "last": "Chang"
                },
                {
                    "first": "Ross D.",
                    "initial": "R.D.",
                    "last": "Shachter"
                },
                {
                    "first": "Douglas K.",
                    "initial": "D.K.",
                    "last": "Owens"
                },
                {
                    "first": "Julie",
                    "initial": "J.",
                    "last": "Parsonnet"
                }
            ],
            "doi": "10.1086/605845",
            "firstpage": "1311",
            "issn": "00221899",
            "lastpage": "1317",
            "pmid": "19751153",
            "pub_year": 2009,
            "title": "Cost-effectiveness of a potential prophylactic helicobacter pylori vaccine in the united states",
            "volume": "200"
        },
        "b0155": {
            "authors": [
                {
                    "first": "J. F.",
                    "initial": "J.F.",
                    "last": "Wyatt"
                },
                {
                    "first": "B. J.",
                    "initial": "B.J.",
                    "last": "Rathbone"
                },
                {
                    "first": "R. V.",
                    "initial": "R.V.",
                    "last": "Heatley"
                }
            ],
            "doi": "10.1136/jcp.39.8.863",
            "firstpage": "863",
            "issn": "00219746",
            "lastpage": "870",
            "pmid": "3528230",
            "pub_year": 1986,
            "title": "Local immune response to gastric Campylobacter in non-ulcer dyspepsia",
            "volume": "39"
        },
        "b0160": {
            "authors": [
                {
                    "first": "Hoda M.",
                    "initial": "H.M.",
                    "last": "Malaty"
                },
                {
                    "first": "David Y.",
                    "initial": "D.Y.",
                    "last": "Graham"
                },
                {
                    "first": "Wendy A.",
                    "initial": "W.A.",
                    "last": "Wattigney"
                },
                {
                    "first": "Sathanur R.",
                    "initial": "S.R.",
                    "last": "Srinivasan"
                },
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Osato"
                },
                {
                    "first": "Gerald S.",
                    "initial": "G.S.",
                    "last": "Berenson"
                }
            ],
            "doi": "10.1086/515105",
            "firstpage": "279",
            "issn": "10584838",
            "lastpage": "282",
            "pmid": "10064244",
            "pub_year": 1999,
            "title": "Natural history of Helicobacter pylori infection in childhood: 12-year follow-up cohort study in a biracial community",
            "volume": "28"
        },
        "b0165": {
            "authors": [
                {
                    "first": "T.",
                    "initial": "T.",
                    "last": "Aebischer"
                },
                {
                    "first": "D.",
                    "initial": "D.",
                    "last": "Bumann"
                },
                {
                    "first": "H. J.",
                    "initial": "H.J.",
                    "last": "Epple"
                },
                {
                    "first": "W.",
                    "initial": "W.",
                    "last": "Metzger"
                },
                {
                    "first": "T.",
                    "initial": "T.",
                    "last": "Schneider"
                },
                {
                    "first": "G.",
                    "initial": "G.",
                    "last": "Cherepnev"
                },
                {
                    "first": "A. K.",
                    "initial": "A.K.",
                    "last": "Walduck"
                },
                {
                    "first": "D.",
                    "initial": "D.",
                    "last": "Kunkel"
                },
                {
                    "first": "V.",
                    "initial": "V.",
                    "last": "Moos"
                },
                {
                    "first": "C.",
                    "initial": "C.",
                    "last": "Loddenkemper"
                },
                {
                    "first": "I.",
                    "initial": "I.",
                    "last": "Jiadze"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Panasyuk"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Stolte"
                },
                {
                    "first": "D. Y.",
                    "initial": "D.Y.",
                    "last": "Graham"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Zeitz"
                },
                {
                    "first": "T. F.",
                    "initial": "T.F.",
                    "last": "Meyer"
                }
            ],
            "doi": "10.1136/gut.2007.145839",
            "firstpage": "1065",
            "issn": "00175749",
            "lastpage": "1072",
            "pmid": "18417532",
            "pub_year": 2008,
            "title": "Correlation of T cell response and bacterial clearance in human volunteers challenged with Helicobacter pylori revealed by randomised controlled vaccination with Ty21a-based Salmonella vaccines",
            "volume": "57"
        },
        "b0170": {
            "authors": [
                {
                    "first": null,
                    "initial": null,
                    "last": "Sutton"
                },
                {
                    "first": null,
                    "initial": null,
                    "last": "Lee"
                }
            ],
            "doi": "10.1046/j.1365-2036.2000.00825.x",
            "firstpage": "1107",
            "issn": "02692813",
            "lastpage": "1118",
            "pmid": "10971226",
            "pub_year": 2000,
            "title": "Review article: Helicobacter pylori vaccines - The current status",
            "volume": "14"
        },
        "b0175": {
            "authors": [
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Malfertheiner"
                },
                {
                    "first": "Viola",
                    "initial": "V.",
                    "last": "Schultze"
                },
                {
                    "first": "Bernd",
                    "initial": "B.",
                    "last": "Rosenkranz"
                },
                {
                    "first": "Stefan H.E.",
                    "initial": "S.H.E.",
                    "last": "Kaufmann"
                },
                {
                    "first": "Timo",
                    "initial": "T.",
                    "last": "Ulrichs"
                },
                {
                    "first": "Deborah",
                    "initial": "D.",
                    "last": "Novicki"
                },
                {
                    "first": "Francesco",
                    "initial": "F.",
                    "last": "Norelli"
                },
                {
                    "first": "Mario",
                    "initial": "M.",
                    "last": "Contorni"
                },
                {
                    "first": "Samuele",
                    "initial": "S.",
                    "last": "Peppoloni"
                },
                {
                    "first": "Duccio",
                    "initial": "D.",
                    "last": "Berti"
                },
                {
                    "first": "Daniela",
                    "initial": "D.",
                    "last": "Tornese"
                },
                {
                    "first": "Jitendra",
                    "initial": "J.",
                    "last": "Ganju"
                },
                {
                    "first": "Emanuela",
                    "initial": "E.",
                    "last": "Palla"
                },
                {
                    "first": "Rino",
                    "initial": "R.",
                    "last": "Rappuoli"
                },
                {
                    "first": "Bruce F.",
                    "initial": "B.F.",
                    "last": "Scharschmidt"
                },
                {
                    "first": "Giuseppe",
                    "initial": "G.",
                    "last": "Del Giudice"
                }
            ],
            "doi": "10.1053/j.gastro.2008.05.054",
            "firstpage": "787",
            "issn": "00165085",
            "lastpage": "795",
            "pmid": "18619971",
            "pub_year": 2008,
            "title": "Safety and Immunogenicity of an Intramuscular Helicobacter pylori Vaccine in Noninfected Volunteers: A Phase I Study",
            "volume": "135"
        },
        "b0180": {
            "authors": [
                {
                    "first": "Jay V.",
                    "initial": "J.V.",
                    "last": "Solnick"
                },
                {
                    "first": "Don R.",
                    "initial": "D.R.",
                    "last": "Canfield"
                },
                {
                    "first": "Lori M.",
                    "initial": "L.M.",
                    "last": "Hansen"
                },
                {
                    "first": "Sima Z.",
                    "initial": "S.Z.",
                    "last": "Torabian"
                }
            ],
            "doi": "10.1128/IAI.68.5.2560-2565.2000",
            "firstpage": "2560",
            "issn": "00199567",
            "lastpage": "2565",
            "pmid": "10768944",
            "pub_year": 2000,
            "title": "Immunization with recombinant Helicobacter pylori urease in specific- pathogen-free rhesus monkeys (Macaca mulatta)",
            "volume": "68"
        },
        "b0185": {
            "authors": [
                {
                    "first": "D. Y.",
                    "initial": "D.Y.",
                    "last": "Graham"
                },
                {
                    "first": "A. R.",
                    "initial": "A.R.",
                    "last": "Opekun"
                },
                {
                    "first": "M. S.",
                    "initial": "M.S.",
                    "last": "Osato"
                },
                {
                    "first": "H. M.T.",
                    "initial": "H.M.T.",
                    "last": "El-Zimaity"
                },
                {
                    "first": "C. K.",
                    "initial": "C.K.",
                    "last": "Lee"
                },
                {
                    "first": "Y.",
                    "initial": "Y.",
                    "last": "Yamaoka"
                },
                {
                    "first": "W. A.",
                    "initial": "W.A.",
                    "last": "Qureshi"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Cadoz"
                },
                {
                    "first": "T. P.",
                    "initial": "T.P.",
                    "last": "Monath"
                }
            ],
            "doi": "10.1136/gut.2003.037499",
            "firstpage": "1235",
            "issn": "00175749",
            "lastpage": "1243",
            "pmid": "15306577",
            "pub_year": 2004,
            "title": "Challenge model for Helicobacter pylori infection in human volunteers",
            "volume": "53"
        },
        "b0190": {
            "authors": [
                {
                    "first": "Thomas H.",
                    "initial": "T.H.",
                    "last": "Ermak"
                },
                {
                    "first": "Paul J.",
                    "initial": "P.J.",
                    "last": "Giannasca"
                },
                {
                    "first": "Richard",
                    "initial": "R.",
                    "last": "Nichols"
                },
                {
                    "first": "Gwendolyn A.",
                    "initial": "G.A.",
                    "last": "Myers"
                },
                {
                    "first": "John",
                    "initial": "J.",
                    "last": "Nedrud"
                },
                {
                    "first": "Richard",
                    "initial": "R.",
                    "last": "Weltzin"
                },
                {
                    "first": "Cynthia K.",
                    "initial": "C.K.",
                    "last": "Lee"
                },
                {
                    "first": "Harold",
                    "initial": "H.",
                    "last": "Kleanthous"
                },
                {
                    "first": "Thomas P.",
                    "initial": "T.P.",
                    "last": "Monath"
                }
            ],
            "doi": "10.1084/jem.188.12.2277",
            "firstpage": "2277",
            "issn": "00221007",
            "lastpage": "2288",
            "pmid": "9858514",
            "pub_year": 1998,
            "title": "Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II-restricted responses",
            "volume": "188"
        },
        "b0195": {
            "authors": [
                {
                    "first": "Steven F.",
                    "initial": "S.F.",
                    "last": "Moss"
                },
                {
                    "first": "Leonard",
                    "initial": "L.",
                    "last": "Moise"
                },
                {
                    "first": "Dong Soo",
                    "initial": "D.S.",
                    "last": "Lee"
                },
                {
                    "first": "Woojin",
                    "initial": "W.",
                    "last": "Kim"
                },
                {
                    "first": "Songhua",
                    "initial": "S.",
                    "last": "Zhang"
                },
                {
                    "first": "Jinhee",
                    "initial": "J.",
                    "last": "Lee"
                },
                {
                    "first": "Arlin B.",
                    "initial": "A.B.",
                    "last": "Rogers"
                },
                {
                    "first": "William",
                    "initial": "W.",
                    "last": "Martin"
                },
                {
                    "first": "Anne S.",
                    "initial": "A.S.",
                    "last": "De Groot"
                }
            ],
            "doi": "10.1016/j.vaccine.2010.12.130",
            "firstpage": "2085",
            "issn": "0264410X",
            "lastpage": "2091",
            "pmid": "21236233",
            "pub_year": 2011,
            "title": "HelicoVax: Epitope-based therapeutic Helicobacter pylori vaccination in a mouse model",
            "volume": "29"
        },
        "b0200": {
            "authors": [
                {
                    "first": "Joshua",
                    "initial": "J.",
                    "last": "Tobias"
                },
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Lebens"
                },
                {
                    "first": "Sun Nyunt",
                    "initial": "S.N.",
                    "last": "Wai"
                },
                {
                    "first": "Jan",
                    "initial": "J.",
                    "last": "Holmgren"
                },
                {
                    "first": "Ann Mari",
                    "initial": "A.M.",
                    "last": "Svennerholm"
                }
            ],
            "doi": "10.1016/j.micpath.2017.02.021",
            "firstpage": "177",
            "issn": "08824010",
            "lastpage": "184",
            "pmid": "28215587",
            "pub_year": 2017,
            "title": "Surface expression of Helicobacter pylori HpaA adhesion antigen on Vibrio cholerae, enhanced by co-expressed enterotoxigenic Escherichia coli fimbrial antigens",
            "volume": "105"
        },
        "b0205": {
            "authors": [
                {
                    "first": "Jing",
                    "initial": "J.",
                    "last": "Yang"
                },
                {
                    "first": "Lv Xia",
                    "initial": "L.X.",
                    "last": "Dai"
                },
                {
                    "first": "Xing",
                    "initial": "X.",
                    "last": "Pan"
                },
                {
                    "first": "Hongren",
                    "initial": "H.",
                    "last": "Wang"
                },
                {
                    "first": "Bei",
                    "initial": "B.",
                    "last": "Li"
                },
                {
                    "first": "Jie",
                    "initial": "J.",
                    "last": "Zhu"
                },
                {
                    "first": "Ming Yuan",
                    "initial": "M.Y.",
                    "last": "Li"
                },
                {
                    "first": "Xin Li",
                    "initial": "X.L.",
                    "last": "Shi"
                },
                {
                    "first": "Bao Ning",
                    "initial": "B.N.",
                    "last": "Wang"
                }
            ],
            "doi": "10.1093/femspd/ftv026",
            "issn": "2049632X",
            "pmid": "25846576",
            "pub_year": 2015,
            "title": "Protection against Helicobacter pylori infection in BALB/c mice by oral administration of multi-epitope vaccine of CTB-UreI-UreB",
            "volume": "73"
        },
        "b0210": {
            "authors": [
                {
                    "first": "Yan",
                    "initial": "Y.",
                    "last": "Li"
                },
                {
                    "first": "Zhongbiao",
                    "initial": "Z.",
                    "last": "Chen"
                },
                {
                    "first": "Jianbin",
                    "initial": "J.",
                    "last": "Ye"
                },
                {
                    "first": "Lijun",
                    "initial": "L.",
                    "last": "Ning"
                },
                {
                    "first": "Jun",
                    "initial": "J.",
                    "last": "Luo"
                },
                {
                    "first": "Lili",
                    "initial": "L.",
                    "last": "Zhang"
                },
                {
                    "first": "Yin",
                    "initial": "Y.",
                    "last": "Jiang"
                },
                {
                    "first": "Yue",
                    "initial": "Y.",
                    "last": "Xi"
                },
                {
                    "first": "Yunshan",
                    "initial": "Y.",
                    "last": "Ning"
                }
            ],
            "doi": "10.1111/hel.12268",
            "firstpage": "234",
            "issn": "10834389",
            "lastpage": "248",
            "pmid": "26332255",
            "pub_year": 2016,
            "title": "Antibody Production and Th1-biased Response Induced by an Epitope Vaccine Composed of Cholera Toxin B Unit and Helicobacter pylori Lpp20 Epitopes",
            "volume": "21"
        },
        "b0215": {
            "authors": [
                {
                    "first": "Xinyang",
                    "initial": "X.",
                    "last": "Li"
                },
                {
                    "first": "Yingying",
                    "initial": "Y.",
                    "last": "Xing"
                },
                {
                    "first": "Le",
                    "initial": "L.",
                    "last": "Guo"
                },
                {
                    "first": "Xiaobo",
                    "initial": "X.",
                    "last": "Lv"
                },
                {
                    "first": "Hui",
                    "initial": "H.",
                    "last": "Song"
                },
                {
                    "first": "Tao",
                    "initial": "T.",
                    "last": "Xi"
                }
            ],
            "doi": "10.1111/2049-632X.12173",
            "firstpage": "78",
            "issn": "2049632X",
            "lastpage": "86",
            "pmid": "24687988",
            "pub_year": 2014,
            "title": "Oral immunization with recombinant Lactococcus lactis delivering a multi-epitope antigen CTB-UE attenuates Helicobacter pylori infection in mice",
            "volume": "72"
        },
        "b0220": null,
        "b0225": {
            "authors": [
                {
                    "first": "Stefanie",
                    "initial": "S.",
                    "last": "W\u00fcstner"
                },
                {
                    "first": "Florian",
                    "initial": "F.",
                    "last": "Anderl"
                },
                {
                    "first": "Andreas",
                    "initial": "A.",
                    "last": "Wanisch"
                },
                {
                    "first": "Corinna",
                    "initial": "C.",
                    "last": "Sachs"
                },
                {
                    "first": "Katja",
                    "initial": "K.",
                    "last": "Steiger"
                },
                {
                    "first": "Andreas",
                    "initial": "A.",
                    "last": "Nerlich"
                },
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Vieth"
                },
                {
                    "first": "Raquel",
                    "initial": "R.",
                    "last": "Mej\u00edas-Luque"
                },
                {
                    "first": "Markus",
                    "initial": "M.",
                    "last": "Gerhard"
                }
            ],
            "doi": "10.1038/s41598-017-14028-1",
            "issn": "20452322",
            "pmid": "29057967",
            "pub_year": 2017,
            "title": "Helicobacter pylori \u03b3-glutamyl transferase contributes to colonization and differential recruitment of T cells during persistence",
            "volume": "7"
        },
        "b0230": {
            "authors": [
                {
                    "first": "Philip",
                    "initial": "P.",
                    "last": "Sutton"
                }
            ],
            "doi": "10.1016/S0140-6736(15)60579-7",
            "firstpage": "1424",
            "issn": "01406736",
            "lastpage": "1425",
            "pmid": "26142047",
            "pub_year": 2015,
            "title": "At last, vaccine-induced protection against Helicobacter pylori",
            "volume": "386"
        },
        "b0235": {
            "authors": [
                {
                    "first": "Natalia",
                    "initial": "N.",
                    "last": "Castan\u00f5-Rodr\u00edguez"
                },
                {
                    "first": "Nadeem O.",
                    "initial": "N.O.",
                    "last": "Kaakoush"
                },
                {
                    "first": "Way Seah",
                    "initial": "W.S.",
                    "last": "Lee"
                },
                {
                    "first": "Hazel M.",
                    "initial": "H.M.",
                    "last": "Mitchell"
                }
            ],
            "doi": "10.1136/gutjnl-2015-310545",
            "firstpage": "235",
            "issn": "00175749",
            "lastpage": "249",
            "pmid": "26508508",
            "pub_year": 2017,
            "title": "Dual role of Helicobacter and Campylobacter species in IBD: A systematic review and meta-analysis",
            "volume": "66"
        },
        "b0240": {
            "authors": [
                {
                    "first": "Yu",
                    "initial": "Y.",
                    "last": "Chen"
                },
                {
                    "first": "Martin J.",
                    "initial": "M.J.",
                    "last": "Blaser"
                }
            ],
            "doi": "10.1001/archinte.167.8.821",
            "firstpage": "821",
            "issn": "00039926",
            "lastpage": "827",
            "pmid": "17452546",
            "pub_year": 2007,
            "title": "Inverse associations of Helicobacter pylori with asthma and allergy",
            "volume": "167"
        },
        "b0245": {
            "authors": [
                {
                    "first": "Tingting",
                    "initial": "T.",
                    "last": "Xie"
                },
                {
                    "first": "Xiaobing",
                    "initial": "X.",
                    "last": "Cui"
                },
                {
                    "first": "Haoxuan",
                    "initial": "H.",
                    "last": "Zheng"
                },
                {
                    "first": "Dong",
                    "initial": "D.",
                    "last": "Chen"
                },
                {
                    "first": "Ling",
                    "initial": "L.",
                    "last": "He"
                },
                {
                    "first": "Bo",
                    "initial": "B.",
                    "last": "Jiang"
                }
            ],
            "doi": "10.1097/MEG.0b013e328363e2c7",
            "firstpage": "1195",
            "issn": "0954691X",
            "lastpage": "1205",
            "pmid": "23839160",
            "pub_year": 2013,
            "title": "Meta-analysis: Eradication of Helicobacter pylori infection is associated with the development of endoscopic gastroesophageal reflux disease",
            "volume": "25"
        }
    },
    "body_text": [
        {
            "endOffset": 15575,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Overview of current efforts"
                }
            ],
            "refoffsets": {
                "b0095": {
                    "endOffset": 15574,
                    "startOffset": 15570
                }
            },
            "secId": "s0015",
            "sentence": "This bacterial longevity indicates the development, on the part of the pathogen, of a range of processes for evading effective host immunity [19].",
            "startOffset": 15429,
            "title": "Biological feasibility for vaccine development"
        },
        {
            "endOffset": 18177,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Overview of current efforts"
                }
            ],
            "secId": "s0015",
            "sentence": "Some study participants were followed for an additional two years, when protection was reported to fall to 55%.",
            "startOffset": 18066,
            "title": "Biological feasibility for vaccine development"
        },
        {
            "endOffset": 17738,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Overview of current efforts"
                }
            ],
            "secId": "s0015",
            "sentence": "The vaccine tested in that trial also contained urease, but was administered orally as a fusion protein joined to the B subunit of heat labile toxin from Escherichia coli.",
            "startOffset": 17567,
            "title": "Biological feasibility for vaccine development"
        },
        {
            "endOffset": 10114,
            "parents": [],
            "refoffsets": {
                "b0060": {
                    "endOffset": 10041,
                    "startOffset": 10037
                }
            },
            "secId": "s0005",
            "sentence": "The prevalence of gastric cancer is particularly high in Asian countries, especially China (where 42% of all new cases of gastric cancer have been reported to occur) [12], Japan and South Korea, where H. pylori infection has a high prevalence.",
            "startOffset": 9871,
            "title": "Helicobacter pylori and associated diseases"
        },
        {
            "endOffset": 26661,
            "parents": [],
            "secId": "s0035",
            "sentence": "The development of an H. pylori vaccine is unlikely to proceed without significant investment from large pharmaceutical companies for late stage development.",
            "startOffset": 26504,
            "title": "Likelihood for financing"
        },
        {
            "endOffset": 15898,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Overview of current efforts"
                }
            ],
            "secId": "s0015",
            "sentence": "However as this clearance is at least partially due to incidental antibiotic treatment, it is not necessarily evidence of naturally acquired immunity, but may rather be drug related.",
            "startOffset": 15716,
            "title": "Biological feasibility for vaccine development"
        },
        {
            "endOffset": 24240,
            "parents": [],
            "secId": "s0030",
            "sentence": "In clinical trial: One potentially important novel approach is that of Imevax, who have completed a Phase I clinical trial with IMX101, a vaccine that comprises the H. pylori antigen \u03b3-glutamyltranspeptidase (GGT), an outer membrane protein and a mucosal adjuvant.",
            "startOffset": 23976,
            "title": "Current status of H. pylori vaccine R&D activities"
        },
        {
            "endOffset": 18762,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Overview of current efforts"
                }
            ],
            "secId": "s0020",
            "sentence": "Current vaccine strategies under development are generally aimed at eradicating H. pylori in order to prevent gastric cancer.",
            "startOffset": 18637,
            "title": "General approaches to vaccine development for this disease for low and middle income country markets"
        },
        {
            "endOffset": 20469,
            "parents": [],
            "secId": "s0025",
            "sentence": "This may be due to the vaccines being tested being insufficiently protective in the mouse before progressing to clinical trial, or it may reflect a degree of poor translatability of protective efficacy between the mouse model and humans, although limitations of the human vaccine studies cannot also be excluded.",
            "startOffset": 20157,
            "title": "Technical and regulatory assessment"
        },
        {
            "endOffset": 14842,
            "parents": [],
            "refoffsets": {
                "b0065": {
                    "endOffset": 14841,
                    "startOffset": 14837
                }
            },
            "secId": "s0005",
            "sentence": "A number of reports have indicated that strategies that screen a population for H. pylori then treat are cost-effective, using a threshold of US$50,000 per life-year saved [13].",
            "startOffset": 14665,
            "title": "Helicobacter pylori and associated diseases"
        },
        {
            "endOffset": 17566,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Overview of current efforts"
                }
            ],
            "refoffsets": {
                "b0115": {
                    "endOffset": 17565,
                    "startOffset": 17561
                }
            },
            "secId": "s0015",
            "sentence": "The exception mentioned above was a Phase III clinical trial performed by Wuhu Kangwei Biological Technology of China [23].",
            "startOffset": 17443,
            "title": "Biological feasibility for vaccine development"
        },
        {
            "endOffset": 22339,
            "parents": [],
            "secId": "s0030",
            "sentence": "In recent years, a number of new H. pylori vaccine development programs have been initiated, predominately by small companies and academic institutions (summarised in Table 1).",
            "startOffset": 22163,
            "title": "Current status of H. pylori vaccine R&D activities"
        },
        {
            "endOffset": 19822,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Overview of current efforts"
                }
            ],
            "secId": "s0020",
            "sentence": "This means that late stage clinical trials will most likely/preferentially be performed in such LMIC as this will allow the testing of vaccine efficacy in the main target population group, as well as potentially be essential in order to provide sufficient individuals who will either become (prophylactic vaccine) or who already are (therapeutic vaccine) infected with H. pylori.",
            "startOffset": 19443,
            "title": "General approaches to vaccine development for this disease for low and middle income country markets"
        },
        {
            "endOffset": 16259,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Overview of current efforts"
                }
            ],
            "refoffsets": {
                "b0165": {
                    "endOffset": 16258,
                    "startOffset": 16254
                }
            },
            "secId": "s0015",
            "sentence": "The best evidence for natural immune-mediated protection against H. pylori infection came from a clinical trial where volunteers were vaccinated then challenged with live bacteria; while the vaccine was ineffective, a proportion of volunteers spontaneously cleared the H. pylori challenge via a mechanism that was associated with a T-helper cell response [33].",
            "startOffset": 15899,
            "title": "Biological feasibility for vaccine development"
        },
        {
            "endOffset": 27713,
            "parents": [],
            "refoffsets": {
                "b0235": {
                    "endOffset": 27712,
                    "startOffset": 27705
                },
                "b0240": {
                    "endOffset": 27712,
                    "startOffset": 27705
                },
                "b0245": {
                    "endOffset": 27712,
                    "startOffset": 27705
                }
            },
            "secId": "s0040",
            "sentence": "While evidence for this is still accumulating, and the level of this effect is also not yet completely certain, a protective role of H. pylori infection appears possible for a number of conditions including oesophageal reflux disease and oesophageal cancer (likely mediated by H. pylori suppression of gastric acid secretion), inflammatory bowel disease and asthma [47\u201349].",
            "startOffset": 27340,
            "title": "Closing remarks"
        },
        {
            "endOffset": 26503,
            "parents": [],
            "secId": "s0035",
            "sentence": "However, several high burden countries are self-procuring, such as China, Korea and Japan, and these have substantial private as well as public markets.",
            "startOffset": 26351,
            "title": "Likelihood for financing"
        },
        {
            "endOffset": 9660,
            "parents": [],
            "refoffsets": {
                "b0055": {
                    "endOffset": 9659,
                    "startOffset": 9655
                }
            },
            "secId": "s0005",
            "sentence": "The most serious consequence of H. pylori infection, and the key reason a vaccine is required, is gastric cancer which globally is the 3rd leading cause of death due to cancer [11].",
            "startOffset": 9479,
            "title": "Helicobacter pylori and associated diseases"
        },
        {
            "endOffset": 15428,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Overview of current efforts"
                }
            ],
            "refoffsets": {
                "b0155": {
                    "endOffset": 15427,
                    "startOffset": 15423
                }
            },
            "secId": "s0015",
            "sentence": "H. pylori infect during childhood and are typically present for life, despite a vigorous host immune response which includes the invading pathogen being coated with antibodies [31].",
            "startOffset": 15247,
            "title": "Biological feasibility for vaccine development"
        },
        {
            "endOffset": 22456,
            "parents": [],
            "secId": "s0030",
            "sentence": "To our knowledge, no large pharmaceutical/biotechnology company has a current H. pylori vaccine development program.",
            "startOffset": 22340,
            "title": "Current status of H. pylori vaccine R&D activities"
        },
        {
            "endOffset": 23447,
            "parents": [],
            "secId": "s0030",
            "sentence": "Another approach tested in recent years has utilised probiotics as a vaccine delivery system.",
            "startOffset": 23354,
            "title": "Current status of H. pylori vaccine R&D activities"
        },
        {
            "endOffset": 8173,
            "parents": [],
            "refoffsets": {
                "b0020": {
                    "endOffset": 8172,
                    "startOffset": 8169
                }
            },
            "secId": "s0005",
            "sentence": "While an estimated one half of the world\u2019s population is infected with H. pylori, the levels of infection are considerably greater in countries of low socio-economic status (a major risk factor for H. pylori infection) [4].",
            "startOffset": 7950,
            "title": "Helicobacter pylori and associated diseases"
        },
        {
            "endOffset": 25249,
            "parents": [],
            "secId": "s0030",
            "sentence": "While the trial is completed, results are not yet available.",
            "startOffset": 25189,
            "title": "Current status of H. pylori vaccine R&D activities"
        },
        {
            "endOffset": 25962,
            "parents": [],
            "secId": "s0035",
            "sentence": "The hepatitis B and C viruses, human papillomavirus and H. pylori are the three most common causes of cancer attributed to infection.",
            "startOffset": 25829,
            "title": "Likelihood for financing"
        },
        {
            "endOffset": 9202,
            "parents": [],
            "refoffsets": {
                "b0035": {
                    "endOffset": 9201,
                    "startOffset": 9196
                },
                "b0040": {
                    "endOffset": 9201,
                    "startOffset": 9196
                }
            },
            "secId": "s0005",
            "sentence": "Infection with H. pylori is a proven cause of a range of diseases including gastric and duodenal ulcers (peptic ulcer disease), gastric MALT (mucosal associated lymphoid tissue) lymphoma, and gastric adenocarcinoma (hereafter gastric cancer) [7,8].",
            "startOffset": 8954,
            "title": "Helicobacter pylori and associated diseases"
        },
        {
            "endOffset": 12635,
            "parents": [],
            "secId": "s0005",
            "sentence": "One critical question is whether the vaccine would be given prophylactically or therapeutically.",
            "startOffset": 12539,
            "title": "Helicobacter pylori and associated diseases"
        },
        {
            "endOffset": 14250,
            "parents": [],
            "secId": "s0005",
            "sentence": "For this reason, protection following therapeutic vaccination is generally considered to be more difficult to achieve than prophylactic vaccination.",
            "startOffset": 14102,
            "title": "Helicobacter pylori and associated diseases"
        },
        {
            "endOffset": 19170,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Overview of current efforts"
                }
            ],
            "secId": "s0020",
            "sentence": "The focus of current and previous studies also seem to generally be aimed at prophylactic vaccination, which would necessitate childhood vaccination, as early in life as possible, in order to protect before acquisition of infection.",
            "startOffset": 18938,
            "title": "General approaches to vaccine development for this disease for low and middle income country markets"
        },
        {
            "endOffset": 28537,
            "parents": [],
            "refoffsets": {
                "b0095": {
                    "endOffset": 28536,
                    "startOffset": 28532
                }
            },
            "secId": "s0040",
            "sentence": "Given the unsuccessful vaccine development program to date, what is most needed are completely innovative approaches to overcome the barriers to the development of this vaccine, in particular those posed by the powerful ability of H. pylori to evade the hosts\u2019 immune attack [19].",
            "startOffset": 28257,
            "title": "Closing remarks"
        },
        {
            "endOffset": 9870,
            "parents": [],
            "refoffsets": {
                "b0055": {
                    "endOffset": 9869,
                    "startOffset": 9865
                }
            },
            "secId": "s0005",
            "sentence": "Gastric cancer is the 5th most common malignancy (\u223c952,000 cases in 2012, 6.8% of all cancers), and the 3rd leading cause of cancer-related deaths worldwide (\u223c723,000 deaths in 2012, 8.8% of all cancers) [11].",
            "startOffset": 9661,
            "title": "Helicobacter pylori and associated diseases"
        },
        {
            "endOffset": 25660,
            "parents": [],
            "secId": "s0030",
            "sentence": "This study provided an important proof of concept that vaccine-induced protection against H. pylori infection is possible.",
            "startOffset": 25538,
            "title": "Current status of H. pylori vaccine R&D activities"
        },
        {
            "endOffset": 18937,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Overview of current efforts"
                }
            ],
            "secId": "s0020",
            "sentence": "Given the majority of cases of gastric cancer occur in LMIC, the development of such a successful vaccine would be expected to have a major health benefit in these countries.",
            "startOffset": 18763,
            "title": "General approaches to vaccine development for this disease for low and middle income country markets"
        },
        {
            "endOffset": 8706,
            "parents": [],
            "refoffsets": {
                "b0025": {
                    "endOffset": 8705,
                    "startOffset": 8702
                }
            },
            "secId": "s0005",
            "sentence": "This decline however does not seem to be universal even within a country, indicating regional effects, for example the prevalence of H. pylori infection was reported as considerably lower in urban compared to rural China (47% versus 66% respectively) in a recent systematic review [5].",
            "startOffset": 8421,
            "title": "Helicobacter pylori and associated diseases"
        },
        {
            "endOffset": 22925,
            "parents": [],
            "refoffsets": {
                "b0195": {
                    "endOffset": 22924,
                    "startOffset": 22920
                }
            },
            "secId": "s0030",
            "sentence": "Preclinical: EpiVax Helicobacter pylori vaccine is an epitope-based vaccine, which involves an initial DNA vaccination followed by a peptide-liposome and which has shown some therapeutic protection in mice [39].",
            "startOffset": 22714,
            "title": "Current status of H. pylori vaccine R&D activities"
        },
        {
            "endOffset": 9479,
            "parents": [],
            "secId": "s0005",
            "sentence": "With the exception of ITP, H. pylori-associated diseases are the result of the extremely chronic gastritis that results from the infection.",
            "startOffset": 9340,
            "title": "Helicobacter pylori and associated diseases"
        },
        {
            "endOffset": 18534,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Overview of current efforts"
                }
            ],
            "secId": "s0015",
            "sentence": "However, it was in fact performed between 2005 and 2007 and the development of this vaccine has been discontinued.",
            "startOffset": 18420,
            "title": "Biological feasibility for vaccine development"
        },
        {
            "endOffset": 13021,
            "parents": [],
            "secId": "s0005",
            "sentence": "Hence a prophylactic vaccine would likely need to be given to children in the first few years of life (to reach the maximum number of the target group while uninfected) but health benefits would occur 5 decades later.",
            "startOffset": 12804,
            "title": "Helicobacter pylori and associated diseases"
        },
        {
            "endOffset": 25804,
            "parents": [],
            "secId": "s0030",
            "sentence": "However, while published in 2015, the trial was actually performed between 2005 and 2007 and development of this vaccine has been discontinued.",
            "startOffset": 25661,
            "title": "Current status of H. pylori vaccine R&D activities"
        },
        {
            "endOffset": 20156,
            "parents": [],
            "secId": "s0025",
            "sentence": "The mouse H. pylori model has some value for initial screening of vaccine candidates, but may have limitations; vaccines shown to have some efficacy in mice have not been effective in clinical trial.",
            "startOffset": 19957,
            "title": "Technical and regulatory assessment"
        },
        {
            "endOffset": 26947,
            "parents": [],
            "secId": "s0035",
            "sentence": "A more robust evaluation of the global disease burden and development of the value proposition for a prophylactic and/or therapeutic vaccine may help to incentivize this investment, considering the scale of the potential market of a preventative of H. pylori associated gastric cancer.",
            "startOffset": 26662,
            "title": "Likelihood for financing"
        },
        {
            "endOffset": 16647,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Overview of current efforts"
                }
            ],
            "refoffsets": {
                "b0100": {
                    "endOffset": 16551,
                    "startOffset": 16544
                },
                "b0170": {
                    "endOffset": 16551,
                    "startOffset": 16544
                }
            },
            "secId": "s0015",
            "sentence": "While vaccinating with a surprisingly wide range of antigens, adjuvants and delivery systems can produce a modest reduction in H. pylori colonization levels in mice (reviewed in [20,34]), an approach to produce reliable sterilizing immunity in animal models has not been developed.",
            "startOffset": 16366,
            "title": "Biological feasibility for vaccine development"
        },
        {
            "endOffset": 24972,
            "parents": [],
            "secId": "s0030",
            "sentence": "This is a novel and interesting approach.",
            "startOffset": 24931,
            "title": "Current status of H. pylori vaccine R&D activities"
        },
        {
            "endOffset": 15170,
            "parents": [],
            "secId": "s0005",
            "sentence": "Given this, these data indicate that vaccinating against H. pylori would be expected to be cost-effective in LMIC with the highest burden of disease.",
            "startOffset": 15021,
            "title": "Helicobacter pylori and associated diseases"
        },
        {
            "endOffset": 11943,
            "parents": [],
            "secId": "s0005",
            "sentence": "In this review therefore, we will focus on current attempts to develop such a vaccine.",
            "startOffset": 11857,
            "title": "Helicobacter pylori and associated diseases"
        },
        {
            "endOffset": 7826,
            "parents": [],
            "refoffsets": {
                "b0005": {
                    "endOffset": 7825,
                    "startOffset": 7820
                },
                "b0010": {
                    "endOffset": 7825,
                    "startOffset": 7820
                }
            },
            "secId": "s0005",
            "sentence": "Evidence suggests oral-oral as a likely common route of transmission; this is supported by the ability to cultivate H. pylori from vomitus or the oral region and analyses of bacterial strains which have indicated common vertical transmission between mothers (but not fathers) and their children [1,2].",
            "startOffset": 7525,
            "title": "Helicobacter pylori and associated diseases"
        },
        {
            "endOffset": 18419,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Overview of current efforts"
                }
            ],
            "secId": "s0015",
            "sentence": "As the results of this trial were published in 2015, there is a perception that this study is recent and part of an ongoing vaccine program.",
            "startOffset": 18279,
            "title": "Biological feasibility for vaccine development"
        },
        {
            "endOffset": 7950,
            "parents": [],
            "refoffsets": {
                "b0015": {
                    "endOffset": 7948,
                    "startOffset": 7945
                }
            },
            "secId": "s0005",
            "sentence": "However transmission by the faecal-oral route is also possible, particularly in areas of poor sanitation (reviewed in [3]).",
            "startOffset": 7827,
            "title": "Helicobacter pylori and associated diseases"
        },
        {
            "endOffset": 17022,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Overview of current efforts"
                }
            ],
            "secId": "s0015",
            "sentence": "However attempts to translate this partial success in animal models to clinical trial have, with a single exception, proven unsuccessful.",
            "startOffset": 16885,
            "title": "Biological feasibility for vaccine development"
        },
        {
            "endOffset": 20622,
            "parents": [],
            "secId": "s0025",
            "sentence": "Either way, there are potential benefits to using an intermediate large animal model to confirm mouse observations before progressing to clinical trial.",
            "startOffset": 20470,
            "title": "Technical and regulatory assessment"
        },
        {
            "endOffset": 20947,
            "parents": [],
            "secId": "s0025",
            "sentence": "Such studies would provide useful data for applications for clinical/regulatory approval prior to human trials.",
            "startOffset": 20836,
            "title": "Technical and regulatory assessment"
        },
        {
            "endOffset": 15715,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Overview of current efforts"
                }
            ],
            "refoffsets": {
                "b0160": {
                    "endOffset": 15714,
                    "startOffset": 15710
                }
            },
            "secId": "s0015",
            "sentence": "There is evidence that some children do spontaneously clear H. pylori infection, in a process that is affected by socioeconomic status [32].",
            "startOffset": 15575,
            "title": "Biological feasibility for vaccine development"
        },
        {
            "endOffset": 13217,
            "parents": [],
            "refoffsets": {
                "b0115": {
                    "endOffset": 13217,
                    "startOffset": 13213
                }
            },
            "secId": "s0005",
            "sentence": "In a clinical trial in China that tested a prophylactic vaccine in children aged 6\u201314, 20% of potential vaccines were excluded as they were already infected with H. pylori upon pre-screening.[23]",
            "startOffset": 13022,
            "title": "Helicobacter pylori and associated diseases"
        },
        {
            "endOffset": 16885,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Overview of current efforts"
                }
            ],
            "refoffsets": {
                "b0140": {
                    "endOffset": 16778,
                    "startOffset": 16774
                }
            },
            "secId": "s0015",
            "sentence": "Of particular importance was the demonstration in mice of the ability to produce protection following therapeutic vaccination [28]; this was probably the first demonstration of therapeutic vaccine efficacy against any bacterial pathogen.",
            "startOffset": 16648,
            "title": "Biological feasibility for vaccine development"
        },
        {
            "endOffset": 21238,
            "parents": [],
            "refoffsets": {
                "b0185": {
                    "endOffset": 21237,
                    "startOffset": 21233
                }
            },
            "secId": "s0025",
            "sentence": "A useful tool which has been developed and proven valuable for early clinical trials is the H. pylori challenge strain [37].",
            "startOffset": 21114,
            "title": "Technical and regulatory assessment"
        },
        {
            "endOffset": 24930,
            "parents": [],
            "secId": "s0030",
            "sentence": "The important feature of this trial is that it is attempting to overcome one mechanism by which H. pylori evades host immunity, which might allow an effective vaccine-mediated response to be developed.",
            "startOffset": 24729,
            "title": "Current status of H. pylori vaccine R&D activities"
        },
        {
            "endOffset": 10904,
            "parents": [],
            "refoffsets": {
                "b0060": {
                    "endOffset": 10903,
                    "startOffset": 10899
                }
            },
            "secId": "s0005",
            "sentence": "Antimicrobial therapy has been considered at a population level in China where trials are ongoing; for example in a recent trial of >184,000 people with a prevalence of infection of 57%, an eradication rate of \u223c73% was achieved [12].",
            "startOffset": 10671,
            "title": "Helicobacter pylori and associated diseases"
        },
        {
            "endOffset": 13552,
            "parents": [],
            "secId": "s0005",
            "sentence": "This therefore demonstrates that a prophylactic vaccine against H. pylori will need to be delivered to very young children if it is to provide a high level of protection.",
            "startOffset": 13382,
            "title": "Helicobacter pylori and associated diseases"
        },
        {
            "endOffset": 17443,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Overview of current efforts"
                }
            ],
            "refoffsets": {
                "b0175": {
                    "endOffset": 17399,
                    "startOffset": 17395
                }
            },
            "secId": "s0015",
            "sentence": "A different approach taken to Phase I trial by Novartis combined three different virulence factors (cagA, vacA and NAP) injected intramuscularly with alum; while shown to be immunogenic [35], this vaccine was subsequently not pursued.",
            "startOffset": 17209,
            "title": "Biological feasibility for vaccine development"
        },
        {
            "endOffset": 23139,
            "parents": [],
            "refoffsets": {
                "b0200": {
                    "endOffset": 23098,
                    "startOffset": 23094
                }
            },
            "secId": "s0030",
            "sentence": "Helicovaxor\u00ae has examined two approaches, one involving a non-pathogenic Vibrio cholerae vaccine strain, engineered to express H. pylori antigens (HpaA, UreB and FlaA) [40], and an inactivated strain of H. pylori.",
            "startOffset": 22926,
            "title": "Current status of H. pylori vaccine R&D activities"
        },
        {
            "endOffset": 12539,
            "parents": [],
            "secId": "s0005",
            "sentence": "Given these diseases are thought to be the result of the chronic inflammation caused by infection, it is conceivable that a vaccine would not necessarily need to eradicate the infection, but could be an immunomodulatory vaccine that prevents gastritis.",
            "startOffset": 12287,
            "title": "Helicobacter pylori and associated diseases"
        },
        {
            "endOffset": 8420,
            "parents": [],
            "secId": "s0005",
            "sentence": "This now appears to also be occurring in many developing countries, although there remain high levels of infection in many countries, particularly in Asia.",
            "startOffset": 8265,
            "title": "Helicobacter pylori and associated diseases"
        },
        {
            "endOffset": 14664,
            "parents": [],
            "secId": "s0005",
            "sentence": "Importantly, while there are few definitive studies, a vaccine against H. pylori that reduces the incidence of gastric cancer will likely be cost-effective in both developed countries and in LMIC.",
            "startOffset": 14468,
            "title": "Helicobacter pylori and associated diseases"
        },
        {
            "endOffset": 9339,
            "parents": [],
            "refoffsets": {
                "b0045": {
                    "endOffset": 9338,
                    "startOffset": 9332
                },
                "b0050": {
                    "endOffset": 9338,
                    "startOffset": 9332
                }
            },
            "secId": "s0005",
            "sentence": "There is reasonable evidence that this infection is also a cause of at least some cases of immune thrombocytopenic purpura (ITP) [9,10].",
            "startOffset": 9203,
            "title": "Helicobacter pylori and associated diseases"
        },
        {
            "endOffset": 17208,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Overview of current efforts"
                }
            ],
            "refoffsets": {
                "b0105": {
                    "endOffset": 17207,
                    "startOffset": 17203
                }
            },
            "secId": "s0015",
            "sentence": "The majority of early H. pylori vaccine clinical trials focused on the urease antigen with different adjuvants, routes and delivery systems generally proving ineffective in humans [21].",
            "startOffset": 17023,
            "title": "Biological feasibility for vaccine development"
        },
        {
            "endOffset": 12139,
            "parents": [],
            "secId": "s0005",
            "sentence": "The primary target group for such a vaccine would be the populations of countries with a high prevalence of H. pylori-associated gastric cancer, which include China, South Korea, Russia and Japan.",
            "startOffset": 11943,
            "title": "Helicobacter pylori and associated diseases"
        },
        {
            "endOffset": 10670,
            "parents": [],
            "secId": "s0005",
            "sentence": "H. pylori infections are currently treatable with combination antimicrobial therapies, although antibiotic resistance is a major concern.",
            "startOffset": 10533,
            "title": "Helicobacter pylori and associated diseases"
        },
        {
            "endOffset": 24728,
            "parents": [],
            "secId": "s0030",
            "sentence": "Hence this vaccine aims to target and neutralize this defense mechanism, potentially allowing for the generation of a more effective protective immune response to be raised against the other antigenic components of the vaccine.",
            "startOffset": 24501,
            "title": "Current status of H. pylori vaccine R&D activities"
        },
        {
            "endOffset": 25188,
            "parents": [],
            "secId": "s0030",
            "sentence": "Given these bacteria appear to have several such defensive strategies, it remains to be seen whether targeting one such mechanism will be sufficient, but it would seem to be a valid strategy worthy of investigation.",
            "startOffset": 24973,
            "title": "Current status of H. pylori vaccine R&D activities"
        },
        {
            "endOffset": 15020,
            "parents": [],
            "refoffsets": {
                "b0150": {
                    "endOffset": 15019,
                    "startOffset": 15015
                }
            },
            "secId": "s0005",
            "sentence": "Additionally, an evaluation of prophylactic vaccination against H. pylori was determined to be cost-effective in the USA, a country with a relatively low burden of disease [30].",
            "startOffset": 14843,
            "title": "Helicobacter pylori and associated diseases"
        },
        {
            "endOffset": 19442,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Overview of current efforts"
                }
            ],
            "secId": "s0020",
            "sentence": "Given the early stage of the vaccines which are currently under development, it is not clear which geographical group will be targeted although it would be expected that this would include countries with high levels of gastric cancer such as China, South Korea and Russia.",
            "startOffset": 19170,
            "title": "General approaches to vaccine development for this disease for low and middle income country markets"
        },
        {
            "endOffset": 23353,
            "parents": [],
            "refoffsets": {
                "b0205": {
                    "endOffset": 23352,
                    "startOffset": 23345
                },
                "b0210": {
                    "endOffset": 23352,
                    "startOffset": 23345
                }
            },
            "secId": "s0030",
            "sentence": "Recently, two early preclinical studies of H. pylori antigen epitope vaccines from Sichuan University (urease subunits) and Southern Medical University (Lp220) have shown limited protection in BALB/c mice [41,42].",
            "startOffset": 23140,
            "title": "Current status of H. pylori vaccine R&D activities"
        },
        {
            "endOffset": 18278,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Overview of current efforts"
                }
            ],
            "secId": "s0015",
            "sentence": "This trial provided proof of concept that a vaccine can protect against natural H. pylori infection.",
            "startOffset": 18178,
            "title": "Biological feasibility for vaccine development"
        },
        {
            "endOffset": 12158,
            "parents": [],
            "secId": "s0005",
            "sentence": "However an anti-H.",
            "startOffset": 12140,
            "title": "Helicobacter pylori and associated diseases"
        },
        {
            "endOffset": 12803,
            "parents": [],
            "refoffsets": {
                "b0110": {
                    "endOffset": 12739,
                    "startOffset": 12735
                }
            },
            "secId": "s0005",
            "sentence": "A key issue in this regard is that while infection predominantly commences from very early in life [22], gastric cancer commonly develops from 50 years of age onwards.",
            "startOffset": 12636,
            "title": "Helicobacter pylori and associated diseases"
        },
        {
            "endOffset": 8954,
            "parents": [],
            "refoffsets": {
                "b0025": {
                    "endOffset": 8784,
                    "startOffset": 8779
                },
                "b0030": {
                    "endOffset": 8784,
                    "startOffset": 8779
                }
            },
            "secId": "s0005",
            "sentence": "As H. pylori infection levels might be stabilizing in developed nations [5,6] and given the high rates of associated disease in developing countries (see below), it would be dangerous to assume the trend of declining infection rates will continue.",
            "startOffset": 8707,
            "title": "Helicobacter pylori and associated diseases"
        },
        {
            "endOffset": 8264,
            "parents": [],
            "secId": "s0005",
            "sentence": "Infection levels have slowly declined in most developed nations over the past few decades.",
            "startOffset": 8174,
            "title": "Helicobacter pylori and associated diseases"
        },
        {
            "endOffset": 12286,
            "parents": [],
            "secId": "s0005",
            "sentence": "pylori vaccine would have a number of additional benefits, including protecting against peptic ulcer disease and MALT lymphoma.",
            "startOffset": 12159,
            "title": "Helicobacter pylori and associated diseases"
        },
        {
            "endOffset": 24384,
            "parents": [],
            "refoffsets": {
                "b0095": {
                    "endOffset": 24383,
                    "startOffset": 24379
                }
            },
            "secId": "s0030",
            "sentence": "A key reason previous vaccines have likely failed to produce complete protection are the immune evasion strategies possessed by H. pylori [19].",
            "startOffset": 24241,
            "title": "Current status of H. pylori vaccine R&D activities"
        },
        {
            "endOffset": 24500,
            "parents": [],
            "refoffsets": {
                "b0125": {
                    "endOffset": 24499,
                    "startOffset": 24489
                },
                "b0130": {
                    "endOffset": 24499,
                    "startOffset": 24489
                },
                "b0225": {
                    "endOffset": 24499,
                    "startOffset": 24489
                }
            },
            "secId": "s0030",
            "sentence": "One of the most important of these is GGT which appears to have quite potent immunosuppressive activity [25,26,45].",
            "startOffset": 24385,
            "title": "Current status of H. pylori vaccine R&D activities"
        },
        {
            "endOffset": 7524,
            "parents": [],
            "secId": "s0005",
            "sentence": "The route of H. pylori transmission has not been definitively proven and remains controversial.",
            "startOffset": 7429,
            "title": "Helicobacter pylori and associated diseases"
        },
        {
            "endOffset": 14101,
            "parents": [],
            "refoffsets": {
                "b0125": {
                    "endOffset": 13992,
                    "startOffset": 13985
                },
                "b0130": {
                    "endOffset": 13992,
                    "startOffset": 13985
                },
                "b0135": {
                    "endOffset": 13992,
                    "startOffset": 13985
                }
            },
            "secId": "s0005",
            "sentence": "The choice of prophylactic versus therapeutic may be critically important as H. pylori can induce a number of immunosuppressive effects that helps to facilitate chronic colonisation [25\u201327]; such features from an established infection would potentially oppose the efficacy of a therapeutic vaccine.",
            "startOffset": 13803,
            "title": "Helicobacter pylori and associated diseases"
        },
        {
            "endOffset": 21113,
            "parents": [],
            "secId": "s0025",
            "sentence": "A key clinical readout for any conventional H. pylori vaccine would be protection against either acquisition (prophylactic) or eradication (therapeutic) of infection.",
            "startOffset": 20947,
            "title": "Technical and regulatory assessment"
        },
        {
            "endOffset": 27339,
            "parents": [],
            "secId": "s0040",
            "sentence": "An interesting observation that has emerged over the last decade has been that H. pylori infection might protect against a number of apparently unrelated diseases.",
            "startOffset": 27176,
            "title": "Closing remarks"
        },
        {
            "endOffset": 13802,
            "parents": [],
            "refoffsets": {
                "b0120": {
                    "endOffset": 13683,
                    "startOffset": 13679
                }
            },
            "secId": "s0005",
            "sentence": "An effective therapeutic vaccine however could be given at almost any age and still potentially protect against gastric cancer [24], although it would perhaps ideally be given before the 4th decade of life to maximize the chance of preventing cancer.",
            "startOffset": 13552,
            "title": "Helicobacter pylori and associated diseases"
        },
        {
            "endOffset": 28256,
            "parents": [],
            "secId": "s0040",
            "sentence": "There is a clear and considerable need for major investment in this area.",
            "startOffset": 28183,
            "title": "Closing remarks"
        },
        {
            "endOffset": 16365,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Overview of current efforts"
                }
            ],
            "secId": "s0015",
            "sentence": "The development of a vaccine to prevent or eradicate H. pylori infection has proven extremely challenging.",
            "startOffset": 16259,
            "title": "Biological feasibility for vaccine development"
        },
        {
            "endOffset": 21721,
            "parents": [],
            "refoffsets": {
                "b0115": {
                    "endOffset": 21720,
                    "startOffset": 21716
                }
            },
            "secId": "s0025",
            "sentence": "Later Phase trials of vaccines aimed at eradicating H. pylori would almost certainly need to measure the effects of prophylactic or therapeutic vaccination on naturally acquired infection, as performed by the published Phase III study from China [23].",
            "startOffset": 21470,
            "title": "Technical and regulatory assessment"
        },
        {
            "endOffset": 11569,
            "parents": [],
            "secId": "s0005",
            "sentence": "An effective vaccine against H. pylori therefore remains a preferential option, especially for LMIC who would particularly benefit given the high prevalence of disease associated with this infection in these countries and the likely lower costs of a vaccine approach as compared to other strategies.",
            "startOffset": 11270,
            "title": "Helicobacter pylori and associated diseases"
        },
        {
            "endOffset": 11270,
            "parents": [],
            "secId": "s0005",
            "sentence": "Antimicrobial eradication is also not expected to protect against reinfection, although this would likely occur at a relatively low rate in adults.",
            "startOffset": 11123,
            "title": "Helicobacter pylori and associated diseases"
        },
        {
            "endOffset": 25537,
            "parents": [],
            "refoffsets": {
                "b0115": {
                    "endOffset": 25536,
                    "startOffset": 25529
                },
                "b0230": {
                    "endOffset": 25536,
                    "startOffset": 25529
                }
            },
            "secId": "s0030",
            "sentence": "As mentioned above, Wuhu Kangwei Biological Technology (renamed Wuhu Kangwei biological technology Co., Ltd. in 2011) has relatively recently published the results of a phase III clinical trial of a H. pylori vaccine which showed efficacy against natural acquisition of infection [23,46].",
            "startOffset": 25249,
            "title": "Current status of H. pylori vaccine R&D activities"
        },
        {
            "endOffset": 27931,
            "parents": [],
            "secId": "s0040",
            "sentence": "Hence if/when an effective vaccine against H. pylori is developed and implemented, it will likely be important to monitor for any negative effects that the removal of H. pylori protection may have on other conditions.",
            "startOffset": 27714,
            "title": "Closing remarks"
        },
        {
            "endOffset": 19956,
            "parents": [],
            "secId": "s0025",
            "sentence": "A number of animal models are available for examining the efficacy of putative H. pylori vaccines.",
            "startOffset": 19858,
            "title": "Technical and regulatory assessment"
        },
        {
            "endOffset": 11856,
            "parents": [],
            "refoffsets": {
                "b0075": {
                    "endOffset": 11855,
                    "startOffset": 11848
                },
                "b0080": {
                    "endOffset": 11855,
                    "startOffset": 11848
                },
                "b0085": {
                    "endOffset": 11855,
                    "startOffset": 11848
                },
                "b0090": {
                    "endOffset": 11855,
                    "startOffset": 11848
                },
                "b0095": {
                    "endOffset": 11855,
                    "startOffset": 11848
                },
                "b0100": {
                    "endOffset": 11855,
                    "startOffset": 11848
                },
                "b0105": {
                    "endOffset": 11855,
                    "startOffset": 11848
                }
            },
            "secId": "s0005",
            "sentence": "There have been a large number of previous reviews, many recent, that provide summaries of earlier efforts to produce an effective H. pylori vaccine, as well as discourse on our understandings of the mechanism of action of previous vaccine attempts (some examples are provided) [15\u201321].",
            "startOffset": 11570,
            "title": "Helicobacter pylori and associated diseases"
        },
        {
            "endOffset": 22112,
            "parents": [],
            "refoffsets": {
                "b0145": {
                    "endOffset": 22111,
                    "startOffset": 22104
                },
                "b0190": {
                    "endOffset": 22111,
                    "startOffset": 22104
                }
            },
            "secId": "s0025",
            "sentence": "Another significant challenge to the development of an effective vaccine is that there is no known/accepted correlate of protection: for the induction of sterilising immunity it was originally expected that such protection would be antibody mediated and that may still prove to be the case, but the limited protection generated in mice at least does not appear to involve antibodies [29,38].",
            "startOffset": 21721,
            "title": "Technical and regulatory assessment"
        },
        {
            "endOffset": 22714,
            "parents": [],
            "secId": "s0030",
            "sentence": "Some of these are discussed briefly below.",
            "startOffset": 22672,
            "title": "Current status of H. pylori vaccine R&D activities"
        },
        {
            "endOffset": 17940,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Overview of current efforts"
                }
            ],
            "secId": "s0015",
            "sentence": "This was the first trial to vaccinate children, to follow vaccinees over a period of years, to study the acquisition of natural infection and to show evidence of protection against H. pylori infection.",
            "startOffset": 17739,
            "title": "Biological feasibility for vaccine development"
        },
        {
            "endOffset": 22551,
            "parents": [],
            "secId": "s0030",
            "sentence": "All H. pylori vaccines currently in development are very early stage (Phase I or preclinical).",
            "startOffset": 22457,
            "title": "Current status of H. pylori vaccine R&D activities"
        },
        {
            "endOffset": 10243,
            "parents": [],
            "refoffsets": {
                "b0065": {
                    "endOffset": 10242,
                    "startOffset": 10235
                },
                "b0070": {
                    "endOffset": 10242,
                    "startOffset": 10235
                }
            },
            "secId": "s0005",
            "sentence": "H. pylori is responsible for the majority of non-cardia gastric cancers, the predominant type of cancers in the stomach [13,14].",
            "startOffset": 10115,
            "title": "Helicobacter pylori and associated diseases"
        },
        {
            "endOffset": 18065,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Overview of current efforts"
                }
            ],
            "secId": "s0015",
            "sentence": "The trial reported that the vaccinations reduced the natural acquisition of H. pylori at one-year post-vaccination by 71.8%.",
            "startOffset": 17941,
            "title": "Biological feasibility for vaccine development"
        },
        {
            "endOffset": 20835,
            "parents": [],
            "refoffsets": {
                "b0180": {
                    "endOffset": 20834,
                    "startOffset": 20830
                }
            },
            "secId": "s0025",
            "sentence": "The Rhesus macaque (Macaca mulatta) provides a quality non-human primate model; captive colonies of macaques are readily (if not already) infected with H. pylori and can be used to screen candidate vaccines [36].",
            "startOffset": 20623,
            "title": "Technical and regulatory assessment"
        },
        {
            "endOffset": 28182,
            "parents": [],
            "secId": "s0040",
            "sentence": "The development of such a vaccine has encountered significant issues; this is reflected in the current status where there is no advanced program and only one vaccine in active clinical development which has recently completed a Phase I clinical trial.",
            "startOffset": 27931,
            "title": "Closing remarks"
        },
        {
            "endOffset": 14468,
            "parents": [],
            "refoffsets": {
                "b0140": {
                    "endOffset": 14377,
                    "startOffset": 14370
                },
                "b0145": {
                    "endOffset": 14377,
                    "startOffset": 14370
                }
            },
            "secId": "s0005",
            "sentence": "However, proof-of-concept has been shown for reducing colonisation by vaccinating mice already infected with H. pylori [28,29], although there is as yet no evidence of therapeutic efficacy against H. pylori in humans.",
            "startOffset": 14251,
            "title": "Helicobacter pylori and associated diseases"
        },
        {
            "endOffset": 13381,
            "parents": [],
            "secId": "s0005",
            "sentence": "Given an estimated 42% of the Chinese population is infected with H. pylori this actually represents potentially half of the individuals that need to be protected.",
            "startOffset": 13218,
            "title": "Helicobacter pylori and associated diseases"
        },
        {
            "endOffset": 23783,
            "parents": [],
            "refoffsets": {
                "b0215": {
                    "endOffset": 23649,
                    "startOffset": 23645
                }
            },
            "secId": "s0030",
            "sentence": "Specifically some protection against H. pylori colonisation was shown in mice orally dosed with Lactococcus lactis recombinantly expressing cholera toxin B subunit and epitopes of H. pylori urease [43], although this did not seem to provide any improvement on the protection typically seen with standard recombinant antigen approaches.",
            "startOffset": 23448,
            "title": "Current status of H. pylori vaccine R&D activities"
        },
        {
            "endOffset": 22671,
            "parents": [],
            "secId": "s0030",
            "sentence": "These vaccines are predominantly composed of purified or recombinant components of H. pylori antigens with an adjuvant.",
            "startOffset": 22552,
            "title": "Current status of H. pylori vaccine R&D activities"
        },
        {
            "endOffset": 10533,
            "parents": [],
            "secId": "s0005",
            "sentence": "There is also considerable morbidity and mortality associated with peptic ulcer disease in many low and middle income countries (LMIC), although as these are also caused by the overuse of non-steroidal anti-inflammatory drugs, it is not always clear how much is due to H. pylori infection.",
            "startOffset": 10244,
            "title": "Helicobacter pylori and associated diseases"
        },
        {
            "endOffset": 23976,
            "parents": [],
            "refoffsets": {
                "b0220": {
                    "endOffset": 23975,
                    "startOffset": 23971
                }
            },
            "secId": "s0030",
            "sentence": "Finally, the Murdoch Children\u2019s Research Institute (MCRI) is developing a vaccine that rather than aiming to eradicate H. pylori, inhibits the inflammation that causes associated disease [44].",
            "startOffset": 23784,
            "title": "Current status of H. pylori vaccine R&D activities"
        },
        {
            "endOffset": 11122,
            "parents": [],
            "refoffsets": {
                "b0060": {
                    "endOffset": 11012,
                    "startOffset": 11008
                }
            },
            "secId": "s0005",
            "sentence": "A failure rate of over one in four, in addition to almost half the volunteers not completing the trial [12], suggest significant challenges for population-wide implementation of antimicrobial eradication of H. pylori.",
            "startOffset": 10905,
            "title": "Helicobacter pylori and associated diseases"
        },
        {
            "endOffset": 27176,
            "parents": [],
            "secId": "s0040",
            "sentence": "In summary, there is a considerable unmet need for a vaccine to protect against diseases associated with H. pylori infection, and specifically gastric cancer which is particularly needed in a large number of LMIC.",
            "startOffset": 26963,
            "title": "Closing remarks"
        },
        {
            "endOffset": 7428,
            "parents": [],
            "secId": "s0005",
            "sentence": "Helicobacter pylori infections of the stomach mucosa typically start in childhood and, unless treated, normally remain for life.",
            "startOffset": 7300,
            "title": "Helicobacter pylori and associated diseases"
        },
        {
            "endOffset": 21469,
            "parents": [],
            "refoffsets": {
                "b0165": {
                    "endOffset": 21468,
                    "startOffset": 21464
                }
            },
            "secId": "s0025",
            "sentence": "This strain, which lacks key pathogenicity factors and that is susceptible to a range of antimicrobials so as to be easily eradicated with antibiotics, has already been used in a Phase I trial to challenge vaccine recipients [33].",
            "startOffset": 21239,
            "title": "Technical and regulatory assessment"
        },
        {
            "endOffset": 26350,
            "parents": [],
            "secId": "s0035",
            "sentence": "GAVI currently provides support to eligible countries for the hepatitis B and human papillomavirus vaccines, suggesting the possibility for financing of an H. pylori vaccine if cost-effectiveness and public health impact can be demonstrated in the contexts of GAVI eligible countries, many of which are in East and Central Asia with the highest burden of H. pylori infection and disease.",
            "startOffset": 25963,
            "title": "Likelihood for financing"
        }
    ],
    "docId": "S0264410X18300173",
    "metadata": {
        "asjc": [
            "1313",
            "2400",
            "2725",
            "2739",
            "3400"
        ],
        "authors": [
            {
                "email": "phil.sutton@mcri.edu.au",
                "first": "Philip",
                "initial": "P.",
                "last": "Sutton"
            },
            {
                "email": null,
                "first": "Joanne M.",
                "initial": "J.M.",
                "last": "Boag"
            }
        ],
        "doi": "10.1016/j.vaccine.2018.01.001",
        "firstpage": "7295",
        "issn": "0264410X",
        "keywords": [
            "Helicobacter pylori",
            "Research and development",
            "Vaccine"
        ],
        "lastpage": "7299",
        "openaccess": "Full",
        "pub_year": 2019,
        "subjareas": [
            "BIOC",
            "IMMU",
            "MEDI",
            "VETE"
        ],
        "title": "Status of vaccine research and development for Helicobacter pylori"
    }
}